PROVIDER PROFILE · NPI 1306807490
Marika Cherfas
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
3,358
Beneficiaries
—
Total drug cost
$2.1M
Distinct drugs
77
Brand share
71.9%
Top prescribed drugs
Lipase/Protease/Amylase198 claims
Icosapent Ethyl194 claims
Cyclosporine159 claims
Dexlansoprazole152 claims
Linaclotide145 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$224
Payment records
4
By payment type
Food and Beverage$224
Top paying entities
Food and Beverage$224
CROSS-REFERENCE